CN100453543C - A temodar synthesis method - Google Patents
A temodar synthesis method Download PDFInfo
- Publication number
- CN100453543C CN100453543C CNB2004100202334A CN200410020233A CN100453543C CN 100453543 C CN100453543 C CN 100453543C CN B2004100202334 A CNB2004100202334 A CN B2004100202334A CN 200410020233 A CN200410020233 A CN 200410020233A CN 100453543 C CN100453543 C CN 100453543C
- Authority
- CN
- China
- Prior art keywords
- temozolomide
- toluene
- described method
- water
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000001308 synthesis method Methods 0.000 title 1
- 229940061353 temodar Drugs 0.000 title 1
- 229960004964 temozolomide Drugs 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 23
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 58
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 45
- 238000003756 stirring Methods 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 28
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 claims description 28
- 238000005406 washing Methods 0.000 claims description 28
- 238000000967 suction filtration Methods 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 22
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 239000012954 diazonium Substances 0.000 claims description 18
- 150000001989 diazonium salts Chemical class 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 239000012452 mother liquor Substances 0.000 claims description 15
- GRRYSIXDUIAUGY-UHFFFAOYSA-N n-methylcarbamoyl chloride Chemical compound CNC(Cl)=O GRRYSIXDUIAUGY-UHFFFAOYSA-N 0.000 claims description 12
- 235000010288 sodium nitrite Nutrition 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000007670 refining Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 230000006698 induction Effects 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 150000002460 imidazoles Chemical class 0.000 claims description 3
- 230000007547 defect Effects 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 31
- 239000000843 powder Substances 0.000 description 16
- -1 imidazoles monohydrate Chemical class 0.000 description 15
- 238000005303 weighing Methods 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 12
- 238000001291 vacuum drying Methods 0.000 description 8
- 238000007363 ring formation reaction Methods 0.000 description 7
- 238000010189 synthetic method Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 241000972773 Aulopiformes Species 0.000 description 5
- 235000019515 salmon Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100202334A CN100453543C (en) | 2004-08-04 | 2004-08-04 | A temodar synthesis method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100202334A CN100453543C (en) | 2004-08-04 | 2004-08-04 | A temodar synthesis method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1730482A CN1730482A (en) | 2006-02-08 |
CN100453543C true CN100453543C (en) | 2009-01-21 |
Family
ID=35962907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100202334A Expired - Lifetime CN100453543C (en) | 2004-08-04 | 2004-08-04 | A temodar synthesis method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100453543C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102070639B (en) * | 2010-12-21 | 2012-10-10 | 中南大学 | Method for synthesizing temozolomide |
CN102659789B (en) * | 2011-04-27 | 2014-10-15 | 四川科瑞德凯华制药有限公司 | Method preparing temozolomide in one-pot mode and refining method of temozolomide |
CN102329319B (en) * | 2011-07-19 | 2014-01-15 | 江苏奥赛康药业股份有限公司 | Novel crystal form for temozolomide, method for preparing temozolomide and medicinal composition of temozolomide |
RU2669777C2 (en) * | 2013-10-29 | 2018-10-16 | Цзянсу Тасли Дии Фармасьютикал Ко., Лтд. | Crystalline forms of temozolomide and method for preparing same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260291A (en) * | 1981-08-24 | 1993-11-09 | Cancer Research Campaign Technology Limited | Tetrazine derivatives |
CN1486319A (en) * | 2001-01-18 | 2004-03-31 | ���鹫˾ | Synthesis of temozolomide and analogs |
-
2004
- 2004-08-04 CN CNB2004100202334A patent/CN100453543C/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260291A (en) * | 1981-08-24 | 1993-11-09 | Cancer Research Campaign Technology Limited | Tetrazine derivatives |
CN1486319A (en) * | 2001-01-18 | 2004-03-31 | ���鹫˾ | Synthesis of temozolomide and analogs |
Non-Patent Citations (4)
Title |
---|
Antitumor Imidazotetrazines. 35. New Synthetic Routes to theAntitumor Drug Temozolomide. Wang, Yongfeng et al.Journal of Organic Chemistry,Vol.62 No.21. 1997 |
Antitumor Imidazotetrazines. 35. New Synthetic Routes to theAntitumor Drug Temozolomide. Wang, Yongfeng et al.Journal of Organic Chemistry,Vol.62 No.21. 1997 * |
Synthetic studies of8-carbamoylimidazo-[5,1-D]-1,2,3,5-tetrazin-4(3H)-one: a keyderivative of antitumor drug temozolomide. Wang, Yongfeng et al.Bioorg. Med. Chem. Lett,Vol.6 No.2. 1996 |
Synthetic studies of8-carbamoylimidazo-[5,1-D]-1,2,3,5-tetrazin-4(3H)-one: a keyderivative of antitumor drug temozolomide. Wang, Yongfeng et al.Bioorg. Med. Chem. Lett,Vol.6 No.2. 1996 * |
Also Published As
Publication number | Publication date |
---|---|
CN1730482A (en) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100430384C (en) | Method for the production of 4-(4-aminophenyl)-3-morpholinon | |
CN108299422B (en) | A kind of preparation method of pa pool former times benefit cloth intermediate | |
CN101020658B (en) | Synthesis process of main cyclic quinoline compound | |
SK280544B6 (en) | Process for the preparation of creatine or creatine-monohydrate | |
CN100453543C (en) | A temodar synthesis method | |
CN102321028A (en) | Method for synthesizing 2-methyl-5-nitroimidazole-1-ethanol | |
CN101735157A (en) | Preparation method of erlotinib hydrochloride | |
CN102659789B (en) | Method preparing temozolomide in one-pot mode and refining method of temozolomide | |
CN101704781B (en) | Preparation method of amino pyridine bromide compound | |
CN103396406B (en) | Preparation method of candesartan cilexetil | |
CN103483324A (en) | New preparation method of lapatinib | |
CN103626772A (en) | Synthetic method for temozolomide and intermediate | |
CN103012288B (en) | Preparation method of 6-chloro-1,3-dimethyluracil | |
CN113105327A (en) | Synthetic method of 4-bromomethyl-2-methyl formate biphenyl | |
CN107721901A (en) | A kind of preparation method of 2 [2 (2,3,5,6 phenyl tetrafluoride amido) phenyl] acetic acid | |
EP2142553B1 (en) | Processes for making zilpaterol and salts thereof | |
CN107118211A (en) | The preparation method of the western croak of Leo | |
CN108586350B (en) | Preparation method of imidazole-2-thioketone compound | |
CN113698430B (en) | Preparation method of herbicide anilofos | |
CN110467617A (en) | A kind of technique of three innovations synthesis 2- amino -5- methyl -4- oxo -3- n-propyl triazolo pyrimidine | |
CN101823986A (en) | Preparation method for tert-butyl carbazate | |
CN102746178B (en) | The preparation method of flutamide | |
CN102977045B (en) | 4-(5-amino-6-hydroxybenzoxazole-2-yl)ammonium benzoate as well as preparation method and application thereof | |
CN106432083A (en) | Compounding method for edaravone | |
JP2022544284A (en) | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylate and 4-aminoquinoline compounds therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: JIANGSU TASLY DIYI PHARMACEUTICAL Co.,Ltd. Assignor: Tianjin Tasly Group Co.,Ltd. Contract record no.: 2011320000042 Denomination of invention: A temodar synthesis method Granted publication date: 20090121 License type: Exclusive License Open date: 20060208 Record date: 20110217 |
|
ASS | Succession or assignment of patent right |
Owner name: TIANSHILI DIYI PHARMACEUTICAL IND CO., LTD., JIANG Free format text: FORMER OWNER: TIANJIN TASLY GROUP CO., LTD. Effective date: 20130507 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300402 BEICHEN, TIANJIN TO: 223002 HUAIAN, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130507 Address after: 223002 Huaian City, Jiangsu province Qingpu Industrial Park of Chaoyang Road No. 168 Patentee after: JIANGSU TASLY DIYI PHARMACEUTICAL Co.,Ltd. Address before: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee before: Tianjin Tasly Group Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20090121 |
|
CX01 | Expiry of patent term |